Tom Shea
Chief Financial Officer

 Mr. Shea brings more than 30 years of professional financial experience in the biopharmaceutical industry to ImmusanT.  Prior to joining ImmusanT, Mr. Shea served as CFO for a number of development stage companies, most notably Albireo Pharma, a clinical-stage company developing products for children with severe liver diseases; CFO and executive vice president for Tolerx, Inc., a clinical-stage immunology company focused on type 1 diabetes from 2005 to 2011; and Cubist Pharmaceuticals, an infectious disease company from 1993 to 2003. Over his career, Mr. Shea has raised approximately $1B of capital.